Ensysce Biosciences
Lindsey Millard currently serves as the Director of Translational Sciences at Ensysce Biosciences, overseeing the integration of non-clinical and clinical interfaces of platform technology. Previously, Lindsey held the role of Associate Director, Program Manager at Bristol Myers Squibb, where management of biomarker deliverables across multiple clinical studies was key. With extensive experience as a consultant and a translational scientist, Lindsey has managed IND enabling studies, pharmacokinetic studies, and provided project management for non-clinical and clinical research. A senior pharmacologist at CTI BioPharma, Lindsey contributed to clinical pharmacology protocols and regulatory submissions. Additionally, experience includes roles at Acucela Inc., University of Washington, University of Arizona, and Ventana Medical Systems. Lindsey holds a PhD in Pharmacology, a Professional Science Masters in Business, and degrees in Biochemistry and Molecular Biophysics.
This person is not in any teams
This person is not in any offices
Ensysce Biosciences
1 followers
Ensysce Biosciences, Inc. (Ensysce) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.